These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 19413702

  • 21. [Polycystic ovary syndrome I. Clinical presentation and treatment].
    Ovesen PG, Møller N, Greisen S, Ingerslev HJ.
    Ugeskr Laeger; 1998 Jan 12; 160(3):260-4. PubMed ID: 9454393
    [Abstract] [Full Text] [Related]

  • 22. Androgen circle of polycystic ovary syndrome.
    Homburg R.
    Hum Reprod; 2009 Jul 12; 24(7):1548-55. PubMed ID: 19279033
    [Abstract] [Full Text] [Related]

  • 23. Pharmacologic treatment of polycystic ovary syndrome.
    Ehrmann DA, Rychlik D.
    Semin Reprod Med; 2003 Aug 12; 21(3):277-83. PubMed ID: 14593550
    [Abstract] [Full Text] [Related]

  • 24. The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment.
    Baldani DP, Skrgatic L, Ougouag R, Kasum M.
    Gynecol Endocrinol; 2018 Feb 12; 34(2):87-91. PubMed ID: 28944709
    [Abstract] [Full Text] [Related]

  • 25. Stress in women: metabolic syndrome and polycystic ovary syndrome.
    Diamanti-Kandarakis E, Economou F.
    Ann N Y Acad Sci; 2006 Nov 12; 1083():54-62. PubMed ID: 17148733
    [Abstract] [Full Text] [Related]

  • 26. The management of insulin resistance in polycystic ovary syndrome.
    Teede HJ, Hutchison SK, Zoungas S.
    Trends Endocrinol Metab; 2007 Sep 12; 18(7):273-9. PubMed ID: 17698366
    [Abstract] [Full Text] [Related]

  • 27. Cardiometabolic features of polycystic ovary syndrome.
    Hoffman LK, Ehrmann DA.
    Nat Clin Pract Endocrinol Metab; 2008 Apr 12; 4(4):215-22. PubMed ID: 18250636
    [Abstract] [Full Text] [Related]

  • 28. Cardiovascular risk factors are reduced with a low dose of acarbose in obese patients with polycystic ovary syndrome.
    Araujo Penna I, Canella PR, Vieira CS, Silva de Sá MF, dos Reis RM, Ferriani RA.
    Fertil Steril; 2007 Aug 12; 88(2):519-22. PubMed ID: 17418836
    [Abstract] [Full Text] [Related]

  • 29. Insulin resistance and polycystic ovary syndrome.
    Galluzzo A, Amato MC, Giordano C.
    Nutr Metab Cardiovasc Dis; 2008 Sep 12; 18(7):511-8. PubMed ID: 18657405
    [Abstract] [Full Text] [Related]

  • 30. Endocrine characteristics of polycystic ovary syndrome (PCOS).
    Szilágyi A, Szabó I.
    Indian J Exp Biol; 2003 Jul 12; 41(7):694-700. PubMed ID: 15255372
    [Abstract] [Full Text] [Related]

  • 31. Treatment of the dyslipidemia of insulin resistance.
    Smith DA.
    Med Clin North Am; 2007 Nov 12; 91(6):1185-210, x. PubMed ID: 17964916
    [Abstract] [Full Text] [Related]

  • 32. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.
    Ibáñez L, de Zegher F.
    Hum Reprod Update; 2006 Nov 12; 12(3):243-52. PubMed ID: 16407452
    [Abstract] [Full Text] [Related]

  • 33. Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome.
    Huang G, Coviello A.
    Curr Opin Endocrinol Diabetes Obes; 2012 Dec 12; 19(6):512-9. PubMed ID: 23108199
    [Abstract] [Full Text] [Related]

  • 34. Pharmacologic therapy of polycystic ovary syndrome.
    Dronavalli S, Ehrmann DA.
    Clin Obstet Gynecol; 2007 Mar 12; 50(1):244-54. PubMed ID: 17304039
    [Abstract] [Full Text] [Related]

  • 35. Polycystic ovary syndrome.
    Homburg R.
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr 12; 22(2):261-74. PubMed ID: 17804299
    [Abstract] [Full Text] [Related]

  • 36. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C.
    J Cardiovasc Med (Hagerstown); 2008 Oct 12; 9(10):987-92. PubMed ID: 18799960
    [Abstract] [Full Text] [Related]

  • 37. Vitamin D in the aetiology and management of polycystic ovary syndrome.
    Thomson RL, Spedding S, Buckley JD.
    Clin Endocrinol (Oxf); 2012 Sep 12; 77(3):343-50. PubMed ID: 22574874
    [Abstract] [Full Text] [Related]

  • 38. Endometrial abnormality in women with polycystic ovary syndrome.
    Shang K, Jia X, Qiao J, Kang J, Guan Y.
    Reprod Sci; 2012 Jul 12; 19(7):674-83. PubMed ID: 22534323
    [Abstract] [Full Text] [Related]

  • 39. Dyslipidemia and oxidative stress in PCOS.
    Macut D, Bjekić-Macut J, Savić-Radojević A.
    Front Horm Res; 2013 Jul 12; 40():51-63. PubMed ID: 24002405
    [Abstract] [Full Text] [Related]

  • 40. Syndromes of hyperandrogenism in women.
    Davis S.
    Aust Fam Physician; 1999 May 12; 28(5):447-51. PubMed ID: 10376368
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.